Great Britain: It will be difficult to bring inflation down to 2%, says Bank of England governor

Great Britain: It will be difficult to bring inflation down to 2%, says Bank of England governor

LONDON (Reuters) – Bringing inflation back to its 2% target will be “tough work” because its recent fall is mainly…
Market: Beijing Stock Exchange prevents major shareholders from selling their shares, sources say

Market: Beijing Stock Exchange prevents major shareholders from selling their shares, sources say

(Reuters) – Major shareholders of companies listed on the Beijing Stock Exchange are de facto blocked from selling their shares,…
Market: ADP declines on the stock market, announcement on a reform of airport regulation-analysts

Market: ADP declines on the stock market, announcement on a reform of airport regulation-analysts

(Reuters) – The share price of the ADP group (formerly Aéroports de Paris) fell on the stock market on Monday,…
Market: The Beijing Stock Exchange prohibits large shareholders from selling their securities

Market: The Beijing Stock Exchange prohibits large shareholders from selling their securities

(News Bulletin 247) – The Beijing Stock Exchange refuses to take into consideration requests to sell securities from “significant” shareholders,…
Adp: The ADP group declines on the stock market, penalized by concerns about regulation

Adp: The ADP group declines on the stock market, penalized by concerns about regulation

(News Bulletin 247) – The airport operator opened very sharply lower on Monday after the Minister of Transport, Clément Beaune,…
Valneva: Valneva-The chikungunya vaccine candidate undergoing accelerated evaluation by the EMA

Valneva: Valneva-The chikungunya vaccine candidate undergoing accelerated evaluation by the EMA

(Reuters) – French drugmaker Valneva said on Monday that the marketing authorization application for its chikungunya vaccine candidate has been…
Sanofi: Sanofi announces a 2nd successful clinical trial of Dupixent for

Sanofi: Sanofi announces a 2nd successful clinical trial of Dupixent for

PARIS (Reuters) – Sanofi plans to seek U.S. marketing authorization for its best-selling anti-inflammatory drug, Dupixent, for the treatment of…
Europe: Europe opens mixed before the publication of several indicators

Europe: Europe opens mixed before the publication of several indicators

PARIS (Reuters) – European stock markets opened hesitantly on Monday, at the start of a week full of crucial publications…
DANONE: Objective raised

DANONE: Objective raised

(News Bulletin 247) – On the basis of a graphical argument, News Bulletin 247 analysts selected DANONE for active investors.…
Market: European stock markets expected to fall, wait-and-see attitude dominates

Market: European stock markets expected to fall, wait-and-see attitude dominates

by CORENTIN CHAPRON PARIS (Reuters) – The main European stock markets are expected to fall at the opening on Monday,…